Qube Research & Technologies (QRT)’s Cellectis CLLS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-112	Closed	-$210	–	3410
2024 Q2	$210	Sell	112 -200	-64%	-$525	﹤0.01%	3384
2024 Q1	$827	Sell	312 -4,165	-93%	-$11.5K	﹤0.01%	4053
2023 Q4	$13.8K	Buy	4,477 +4,437	+11,093%	+$10.5K	﹤0.01%	3553
2023 Q3	$63	Buy	+40	New	+$78	﹤0.01%	3798
2021 Q4	–	Sell	-11,310	Closed	-$143K	–	2577
2021 Q3	$143K	Sell	11,310 -47,756	-81%	-$661K	﹤0.01%	1732
2021 Q2	$914K	Buy	59,066 +7,261	+14%	+$122K	0.01%	984
2021 Q1	$1.05M	Buy	51,805 +42,921	+483%	+$1.06M	0.02%	827
2020 Q4	$240K	Buy	+8,884	New	+$199K	﹤0.01%	1455

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLLS Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Cellectis (CLLS) in Q3 2024, closing a stake of 112 shares — an estimated $210 sold.

Qube Research & Technologies (QRT) first reported a position in CLLS in Q4 2020 and held it in 8 quarters. The position peaked at $1.05M in Q1 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining Cellectis position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 112 Cellectis shares in Q3 2024, an estimated $210.
Qube Research & Technologies (QRT) first reported a position in Cellectis in Q4 2020 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Cellectis position peaked at $1.05M in Q1 2021.
27 funds tracked by Wall St. Rank held Cellectis as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.